Hyperfine (Hyperfine) ROCE % : -51.60% (As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Hyperfine ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Hyperfine's annualized ROCE % for the quarter that ended in Dec. 2023 was -51.60%.

Hyperfine ROCE % Historical Data

The historical data trend for Hyperfine's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hyperfine ROCE % Chart

Hyperfine Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

ROCE %

-69.38

-48.84

-51.05

-47.36

-45.68

Hyperfine Quarterly Data
	Dec19	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
ROCE %	Get a 7-Day Free Trial										-41.76	-43.57	-42.77	-47.17	-51.60

Hyperfine ROCE % Calculation

Hyperfine's annualized ROCE % for the fiscal year that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	-48.115	/	( ( (134.051 - 8.803)	+	(94.199 - 8.768) )	/ 2 )
	=	-48.115	/	( (125.248	+	85.431)	/ 2 )
	=	-48.115	/	105.3395
	=	-45.68 %

Hyperfine's ROCE % of for the quarter that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Dec. 2023 )		(Q: Sep. 2023 )		(Q: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Dec. 2023 )		(Q: Sep. 2023 )		(Q: Dec. 2023 )
	=	-46.516	/	( ( (103.064 - 8.211)	+	(94.199 - 8.768) )	/ 2 )
	=	-46.516	/	( ( 94.853	+	85.431 )	/ 2 )
	=	-46.516	/	90.142
	=	-51.60 %

(1) Note: The EBIT data used here is four times the quarterly (Dec. 2023) EBIT data.

Hyperfine (NAS:HYPR) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Hyperfine ROCE % Related Terms

Thank you for viewing the detailed overview of Hyperfine's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Hyperfine (Hyperfine) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Hyperfine Inc (NAS:HYPR) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

N/A

Address

351 New Whitfield Street, Guilford, CT, USA, 06437

Website

https://www.hyperfine.io

Hyperfine Inc is a medical device company that created Swoop. The Swoop Portable MR Imaging System produces high-quality images at a lower magnetic field strength than conventional MRI scanners. Legacy Hyperfine and Liminal represent two operating segments of the company. The company derives its sales from the following sources: 1) device sales which consist of sales of MRI devices and 2) service sales which consist of sales from subscriptions of bundled devices, maintenance, and software.

Executives

Thomas Teisseyre	officer: Chief Operating Officer	C/O HYPERFINE, INC., 351 NEW WHITFIELD STREET, GUILFORD CT 06437
Khan Siddiqui	officer: See Remarks	530 OLD WHITFIELD STREET, GUILFORD CT 06437
Brett Hale	officer: Chief Administrative Officer	C/O HYPERFINE, INC., 351 NEW WHITFIELD STREET, GUILFORD CT 06437
Maria Sainz	director	C/O ORTHOFIX INTERNATIONAL N. V., 3451 PLANO PARKWAY, LEWISVILLE TX 75056
Jonathan M Rothberg	director, 10 percent owner	C/O BUTTERFLY NETWORK, INC., 530 OLD WHITFIELD ST., GUILFORD CT 06437
Alok Gupta	officer: Chief Financial Officer	530 OLD WHITFIELD STREET, GUILFORD CT 06437
Neela Paykel	officer: Gen Counsel & Corp Secretary	530 OLD WHITFIELD STREET, GUILFORD CT 06437
David D Scott	director, officer: President and CEO	530 OLD WHITFIELD STREET, GUILFORD CT 06437
Ruth A Fattori	director	1303 EAST ALGONQUIN ROAD, SCHAUMBURG IL 60196
Hc Sponsor Llc	10 percent owner	31 HUDSON YARDS, 10TH FLOOR, 28TH FLOOR, NEW YORK NY 10001
Arthur Bruce Cohen	10 percent owner	12 SOUTH MAIN STREET, SUITE #203, NORWALK CT 06854
Healthcor Group, Llc	10 percent owner	31 HUDSON YARDS, 10TH FLOOR, NEW YORK NY 10001
Joseph Patrick Healey	10 percent owner	31 HUDSON YARDS, 10TH FLOOR, NEW YORK NY 10001
R Scott Huennekens	director	C/O VOLCANO CORPORATION, 11455 EL CAMINO REAL, SUITE 460, SAN DIEGO CA 92130
Scott A. White	officer: Chief Commercial Officer	530 OLD WHITFIELD STREET, GUILFORD CT 06437